Key facts
- It has raised $7.6M; the latest was Later Stage VC ($1.7M) in Nov 2025.
- Notable investors include Oost NL, Holland Capital (Private Equity), University of Twente Theses, University of Twente Endowment, Business and Technology Center Twente — 8 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 8 names
- ·Watchlist + deal alerts for Uneedle
- ·The full record, as it builds
Funding rounds
No funding rounds for Uneedle are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Uneedle
Developer of innovative silicon intradermal microneedles designed for intradermal use in vaccination and aesthetics. The company uses silicon technology to offer an easy-to-use injection for the intradermal route of drug administration, and its devices eliminate needle fear and inject directly into the skin, targeting the dendritic cells and the immune system very efficiently, enabling healthcare professionals to reduce the required vaccine dose by a significant factor.
- Sector
- Healthcare
- HQ
- Enschede, Netherlands
- Founded
- 2008
- Employees
- 19
- Website
- uneedle.com/
- Ownership
- Privately Held (backing)
Uneedle doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Uneedle shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Uneedle in its N-PORT filings yet. We sweep new filings monthly.